Previous 10 | Next 10 |
GreenLight Biosciences press release ( NASDAQ: GRNA ): Q2 GAAP EPS of -$0.42. Revenue of $1.77M (+261.2% Y/Y). Cash, cash equivalents, and marketable securities were $44.1 million as of June 30, 2022, compared to $31.4 million as of December 31, 2021. For further...
GreenLight raised $108.4 million in private placement led by S2G Ventures with strong participation from existing and new investors with cash expected to fund critical programs through the first half of 2023. GreenLight and Samsung Biologics completed their first commercia...
GreenLight Biosciences ( NASDAQ: GRNA ) announced a private placement of ~$109M; financing includes participation from new and existing institutional investors. The company has agreed to sell ~27.8M shares to a select group of institutional and accredited investo...
BOSTON, Aug. 12, 2022 (GLOBE NEWSWIRE) -- GreenLight Biosciences (Nasdaq: GRNA), a public benefit corporation striving to bring effective and safe solutions to make food clean and affordable for everyone and dedicated to developing health solutions for every person on our planet, today...
Gainers: InVivo Therapeutics Holdings ( NVIV ) +164% . ChemoCentryx ( CCXI ) +109% . Minerva Neurosciences ( NERV ) +104% . Missfresh ( MF ) +66% . Society Pass ( SOPA ) +49% . Greenpro Capital ( GRNQ ) +48% . Yel...
GreenLight Biosciences Holdings (NASDAQ: GRNA) is absolutely crushing it today, with the stock skyrocketing 42% as of 11:37 a.m. ET on Thursday. The company didn't announce any new developments. Instead, today's huge gain reflects continued strong momentum from a big announcement ea...
Gainers: InVivo Therapeutics ( NVIV ) +114% . ChemoCentryx CCXI +108% . GreenLight Biosciences ( GRNA ) +56% . Global Blood Therapeutics GBT +37% . NanoViricides ( NNVC ) +29% . Losers: Helius Medical Technologies ( HSDT...
InVivo Therapeutics Holdings ( NVIV ) +106% . GreenLight Biosciences ( GRNA ) +94% . NanoViricides ( NNVC ) +48% stock skyrockets 50% on start of drug development program for monkeypox. Exicure ( XCUR ) +39% . Global Blood Therapeuti...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: f11photo/Shutterstock.com It’s time for another dive into the biggest pre-market stock movers as we see what’s affecting shares on Thursday! Penny stocks rule the markets this morning as trader...
GreenLight Biosciences ( NASDAQ: GRNA ) and partner Samsung Biologics announced the successful completion of the first commercial-scale engineering run for the companies' mRNA COVID-19 vaccine. After the announcement of the partnership, technology transfer and sc...
News, Short Squeeze, Breakout and More Instantly...
GreenLight Biosciences Holdings PBC Company Name:
GRNA Stock Symbol:
NASDAQ Market:
GreenLight Biosciences Holdings PBC (GRNA) is expected to report for Q2 2023
LEXINGTON, Mass., July 24, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences Holdings, PBC (NASDAQ: GRNA) (“GreenLight” or the “Company”) today announced the closing of its previously announced merger with SW MergerCo, Inc. (“Merger Sub”) and SW ParentCo, I...
NEW YORK, NY / ACCESSWIRE / June 26, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Conformis, Inc. (NASDAQ:CFMS)'s sale t...